Who are Nevoa Life Sciences Holdings, Inc.'s investors?

Nevoa Life Sciences Holdings, Inc.'s investors include Red Cell Incubation.

How much funding has Nevoa Life Sciences Holdings, Inc. raised?

Nevoa Life Sciences Holdings, Inc. has disclosed $16.4M raised across 4 rounds.

Where is Nevoa Life Sciences Holdings, Inc. headquartered?

Nevoa Life Sciences Holdings, Inc. is headquartered in Gilbert, US.

Nevoa Life Sciences Holdings, Inc.

Gilbert, US · Founded 2017 · Delaware corporation · 1 known investors

Find your way into Nevoa Life Sciences Holdings, Inc.

Founders & leadership

Martin McGonagleinChief Executive Officer

Ernest CunninghaminPresident and Chief Operating Officer

Charles RisleyNamed on SEC filing

Robert HartNamed on SEC filing

Board

Tim Barone inBoard directorCo-Founder, Hunted Labs at Red Cell Incubation

Joe DamicoBoard director

Brad EdwardsBoard director

Mike HudsonBoard director

Lou LaskisBoard director

Sanan AbhayBoard director

Dan BueschelBoard director

Investors · 1

Red Cell IncubationreportedTysonsvia Tim Barone · board

Reported raises · per SEC filings

Form D private placements

$16.4M disclosed across 4 rounds · 2018–2024

▶$5.9MraisedJan 2025 · 5 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Brad EdwardsDirector
Tim BaroneDirector
Mike HudsonDirector
Lou LaskisDirector
Sanan AbhayDirector
Martin McGonagleExecutive Officer, Director
Joe DamicoDirector
Ernest CunninghamExecutive Officer
Dan BueschelDirector

Offering amount: $5.9M
Amount sold: $5.9M
First sale: Dec 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.2MraisedMar 2022 · 4 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Daniel BueschelDirector
Timothy BaroneDirector
Michael HudsonExecutive Officer, Director
Allen ArroyoExecutive Officer
Ernest CunninghamExecutive Officer
Louis LaskisDirector
Brad EdwardsDirector

Offering amount: $12M
Amount sold: $6.2M
Proceeds to insiders: $200K
First sale: Jan 2022
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.9MraisedNov 2019 · 10 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

ERNEST CUNNINGHAMExecutive Officer
ROBERT HARTDirector
LOUIS LASKISDirector
JOSEPH DAMICODirector
MICHAEL HUDSONDirector
TIMOTHY BARONEDirector

Amount sold: $2.9M
Minimum investment: $50K
Placement agents: CADRE ADVISORS LLC
First sale: Jul 2019
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.5MraisedNov 2018 · 11 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Charles RisleyDirector
Timothy BaroneDirector
Robert HartDirector
Michael HudsonDirector
Louis LaskisDirector
Ernest CunninghamExecutive Officer

Offering amount: $1.5M
Amount sold: $1.5M
Minimum investment: $50K
First sale: Jul 2018
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Nevoa Life Sciences Holdings, Inc.'s investors?: Nevoa Life Sciences Holdings, Inc.'s investors include Red Cell Incubation.
How much funding has Nevoa Life Sciences Holdings, Inc. raised?: Nevoa Life Sciences Holdings, Inc. has disclosed $16.4M raised across 4 rounds.
Where is Nevoa Life Sciences Holdings, Inc. headquartered?: Nevoa Life Sciences Holdings, Inc. is headquartered in Gilbert, US.